LON:DXRX Diaceutics (DXRX) Share Price, News & Analysis GBX 131 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range 130▼ 13250-Day Range 118▼ 13452-Week Range 82▼ 136Volume83,328 shsAverage Volume104,364 shsMarket Capitalization£110.60 millionP/E Ratio10,500.00Dividend YieldN/APrice TargetGBX 150 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades Get Diaceutics alerts: Email Address Diaceutics MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside14.5% UpsideGBX 150 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares£5.15 M Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.94 out of 5 stars 2.5 Analyst's Opinion Consensus RatingDiaceutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageDiaceutics has only been the subject of 1 research reports in the past 90 days.Read more about Diaceutics' stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for DXRX. Previous Next 0.0 Dividend Strength Dividend YieldDiaceutics does not currently pay a dividend.Dividend GrowthDiaceutics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DXRX. Previous Next 1.2 News and Social Media Coverage News SentimentDiaceutics has a news sentiment score of 0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Diaceutics insiders have bought more of their company's stock than they have sold. Specifically, they have bought £51,516.08 in company stock and sold GBX 0 in company stock.Percentage Held by Insiders34.54% of the stock of Diaceutics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions53.14% of the stock of Diaceutics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Diaceutics' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Diaceutics is 10,500.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 143.26.Price to Earnings Ratio vs. SectorThe P/E ratio of Diaceutics is 10,500.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 169.33.Price to Book Value per Share RatioDiaceutics has a P/B Ratio of 2.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> About Diaceutics Stock (LON:DXRX)Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.Read More DXRX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DXRX Stock News HeadlinesOctober 26, 2023 | finance.yahoo.comDiaceutics (LON:DXRX) shareholders have endured a 41% loss from investing in the stock three years agoOctober 26, 2023 | finance.yahoo.comDiaceutics First Half 2023 Earnings: EPS Beats ExpectationsJuly 26, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.October 26, 2023 | finance.yahoo.comCalculating The Intrinsic Value Of Diaceutics PLC (LON:DXRX)April 20, 2023 | finance.yahoo.comDiaceutics PLC (LON:DXRX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies AheadApril 20, 2023 | finance.yahoo.comDiaceutics PLC (LON:DXRX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?April 17, 2023 | marketwatch.comDiaceutics 2022 Pretax Profit Rose on Growing DemandMarch 13, 2023 | marketwatch.comDiaceutics Suspends Share Trading as SVB Closure Restricts Access to Its FundsJuly 26, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 10, 2023 | finance.yahoo.comThose who invested in Diaceutics (LON:DXRX) a year ago are up 13%January 28, 2023 | finance.yahoo.comBroker Revenue Forecasts For Diaceutics PLC (LON:DXRX) Are Surging HigherJanuary 27, 2023 | lse.co.ukTRADING UPDATES: Diaceutics wins two deals; Faron proposes placingDecember 9, 2022 | finance.yahoo.comAn Intrinsic Calculation For Diaceutics PLC (LON:DXRX) Suggests It's 40% UndervaluedNovember 28, 2022 | msn.comDanske Bank supported the purchase of the new building at Kings Hall Life Sciences ParkSeptember 29, 2022 | finance.yahoo.comEdited Transcript of DXRX.L earnings conference call or presentation 28-Sep-22 12:00pm GMTSeptember 16, 2022 | nz.finance.yahoo.comDEWA and WGEO Complete Preparations for 8th Edition of the World Green Economy SummitSeptember 16, 2022 | yahoo.comBake Off star Laura Adlington reveals she was left suicidal after trolls fat-shamed her on social mediaAugust 14, 2022 | uk.finance.yahoo.comDiaceutics PLC (DXRX.L)See More Headlines Receive DXRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolLON:DXRX CUSIPN/A CIKN/A Webwww.diaceutics.com PhoneN/AFaxN/AEmployees151Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 150 High Stock Price TargetGBX 150 Low Stock Price TargetGBX 150 Potential Upside/Downside+14.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio10,500.00 Forward P/E Ratio42.12 P/E GrowthN/ANet IncomeN/A Net Margins0.03% Pretax MarginN/A Return on Equity0.01% Return on Assets-0.72% Debt Debt-to-Equity Ratio3.07 Current Ratio7.99 Quick Ratio9.92 Sales & Book Value Annual Sales£21.90 million Price / Sales5.05 Cash FlowGBX 41.99 per share Price / Cash Flow3.12 Book ValueGBX 49 per share Price / Book2.67Miscellaneous Outstanding Shares84,430,000Free FloatN/AMarket Cap£110.60 million OptionableNot Optionable Beta0.47 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Ryan Keeling (Age 42)CEO & Director Comp: $334.27kMr. Peter Keeling (Age 64)Founder & Executive Director Comp: $363.24kMr. Nicholas Stewart Roberts (Age 42)CFO & Director Comp: $180.37kMs. Julie BrowneChief Operating OfficerMs. Gillian ShawGeneral CounselMs. Norma ThompsonGlobal Head of Human ResourcesMr. Jordan ClarkChief Commercial OfficerMs. Susanne MunkstedChief Precision Medicine OfficerMs. Jillian BeggsChief Commercial OfficerMs. Marieke HoefsmitSenior Director & Head of Data Delivery NetherlandsMore ExecutivesKey CompetitorsANGLELON:AGLVerici DxLON:VRCIYourgene HealthLON:YGENAbingdon HealthLON:ABDXGENinCodeLON:GENIView All CompetitorsInsidersNick RobertsBought 122 shares on 6/28/2024Total: £122.00 ($1.00/share)Graham PatersonBought 39,934 shares on 5/22/2024Total: £5.15 M ($129.00/share)Peter KeelingSold 750,000 sharesTotal: £76.50 M ($102.00/share)Graham PatersonBought 33,564 shares on 3/6/2024Total: £3.32 M ($99.00/share)Nick RobertsBought 152 shares on 1/30/2024Total: £152.00 ($1.00/share)View All Insider Transactions DXRX Stock Analysis - Frequently Asked Questions How have DXRX shares performed this year? Diaceutics' stock was trading at GBX 87 at the beginning of the year. Since then, DXRX stock has increased by 50.6% and is now trading at GBX 131. View the best growth stocks for 2024 here. How do I buy shares of Diaceutics? Shares of DXRX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:DXRX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Diaceutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Diaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.